AI-powered COVID-19 supplier risk index and demand planning toolkit

AI 支持的 COVID-19 供应商风险指数和需求规划工具包

基本信息

  • 批准号:
    57745
  • 负责人:
  • 金额:
    $ 9.49万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Feasibility Studies
  • 财政年份:
    2020
  • 资助国家:
    英国
  • 起止时间:
    2020 至 无数据
  • 项目状态:
    已结题

项目摘要

For health systems to better prepare and plan for the months ahead, Vamstar will create a risk-based framework to understand supply chain gaps and the evolving demand at a hospital-level in the UK and EU. Additionally, the risk based framework will power the scenario forecasts so that not only the relevant risks are identified but the impact of demand fluctuations assessed in real-time for action planning. The objective of the risk scoring matrix, scenario forecasts, and the Demand-Planning-Toolkit is to focus on the most vulnerable parts of the health systems in Europe and facilitate decision making as quickly as possible. With the supply risk framework, we will be able to predict changes in the overall demand for various essential products and services needed to manage a crisis like COVID-19 and direct the focus of suppliers towards the most needed parts of the care delivery. Combining this with scenario forecasts and the Demand-Planning-Toolkit, Vamstar will be able to assess which suppliers have fulfilled a current order in the market and make predictions about when they will become fully production-ready to sell again. The supply scenario forecasts will be able to predict the impact on supplies as the countries experience various degrees of demand shock across categories. Additionally, the risk scoring framework and Demand-Planning-Toolkit will help stakeholders in the care delivery chain quickly assess countries that have developed or are developing preventative infrastructure and share the findings. This framework and connected real-time supply chain analytics will ensure that in the future such crises are managed with a more proactive strategy vs a reactive supply chain approach currently prevalent in our health systems. By analysing this dataset through artificial intelligence, we want to understand the Pandemic-Supply-Risk and Scenario-Forecasts both from a macro (ability) and micro (willingness) levels needed to manage a pandemic like COVID-19. This toolkit includes necessary items such as face masks but also digital platforms that will aid in patient and population health management across these countries as it undergoes a rapid transformation. Vamstar offers a data science powered platform for predicting and matching public contracts in healthcare and will create an automated "pandemic preparedness toolkit" specifically by using supply chain risk scoring matrix so as to focus on the most vulnerable parts of the health systems affected by the COVID-19 pandemic. It will leverage EU and UK data on public and private tendering, pricing sources and economic annual datasets to do this. Machine learning (ML) and deep learning will be used for tasks such as predicting ongoing list of suppliers with spare capacity, the date of shortages, and prices of key supplies. These predictions and analysis will form part of reports and an autonomous dashboard that will benefit the NHS hospitals and healthcare suppliers.
为了使卫生系统更好地为未来几个月做好准备和计划,Vamstar将创建一个基于风险的框架,以了解英国和欧盟医院层面的供应链缺口和不断变化的需求。此外,基于风险的框架将为情景预测提供动力,以便不仅确定相关风险,而且实时评估需求波动的影响,以便制定行动计划。风险评分矩阵、情景预测和需求规划工具包的目标是将重点放在欧洲卫生系统中最脆弱的部分,并尽快促进决策。有了供应风险框架,我们将能够预测管理COVID-19等危机所需的各种基本产品和服务的总体需求变化,并将供应商的重点引导到最需要的医疗服务部分。结合情景预测和需求计划工具包,Vamstar将能够评估哪些供应商已经完成了市场上当前的订单,并预测他们何时能够完全生产并再次销售。供应情景预测将能够预测当各国经历不同程度的不同类别的需求冲击时对供应的影响。此外,风险评分框架和需求规划工具包将帮助保健服务链中的利益攸关方快速评估已开发或正在开发预防性基础设施的国家,并分享调查结果。这一框架和连接的实时供应链分析将确保今后以更积极主动的战略管理此类危机,而不是目前在我们的卫生系统中普遍存在的被动供应链方法。通过人工智能分析该数据集,我们希望从宏观(能力)和微观(意愿)两个层面了解管理COVID-19等大流行所需的大流行-供应-风险和场景-预测。该工具包包括口罩等必要物品,但也包括数字平台,这些平台将有助于在这些国家经历快速转型的过程中对患者和人口健康进行管理。Vamstar提供了一个数据科学驱动的平台,用于预测和匹配医疗保健领域的公共合同,并将专门通过使用供应链风险评分矩阵创建一个自动化的“大流行准备工具包”,从而专注于受COVID-19大流行影响的卫生系统中最脆弱的部分。它将利用欧盟和英国关于公共和私人招标、定价来源和经济年度数据集的数据来实现这一目标。机器学习(ML)和深度学习将用于预测有闲置产能的供应商名单、短缺日期和关键供应品的价格等任务。这些预测和分析将成为报告和自动仪表板的一部分,这将使NHS医院和医疗保健供应商受益。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Studentship

相似海外基金

AI-powered real-time healthcare supplier profile and COVID-19 supply risk matrix (Resilience Fund)
AI 驱动的实时医疗保健供应商概况和 COVID-19 供应风险矩阵(弹性基金)
  • 批准号:
    10024605
  • 财政年份:
    2021
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Collaborative R&D
Development of Ultral Low Powered Inertial Sensing Technology for battery Powered IoT devices - Covid Resilience
用于电池供电物联网设备的超低功耗惯性传感技术的开发 - Covid Resilience
  • 批准号:
    10024668
  • 财政年份:
    2021
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Collaborative R&D
AI-powered real-time healthcare supplier profile and COVID-19 supply risk matrix
AI 驱动的实时医疗保健供应商概况和 COVID-19 供应风险矩阵
  • 批准号:
    90205
  • 财政年份:
    2021
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Collaborative R&D
Data Science powered healthcare supply chain network monitoring system in the post-COVID and post-Brexit industrial landscape
新冠疫情后和英国脱欧后工业格局中数据科学驱动的医疗保健供应链网络监控系统
  • 批准号:
    97899
  • 财政年份:
    2021
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Collaborative R&D
SBIR Phase II: An AI-powered wearable system and platform for long-term remote monitoring of pulmonary function (COVID-19)
SBIR 第二阶段:人工智能驱动的可穿戴系统和平台,用于长期远程监测肺功能(COVID-19)
  • 批准号:
    2112096
  • 财政年份:
    2021
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Cooperative Agreement
An AI powered data platform to help researchers rapidly identify and evaluate research reagents to investigate and mitigate the effects of COVID-19
人工智能驱动的数据平台,可帮助研究人员快速识别和评估研究试剂,以调查和减轻 COVID-19 的影响
  • 批准号:
    76378
  • 财政年份:
    2020
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Collaborative R&D
Self Powered Door Opening System Removing Contact & Transmission Points for Both Covid-19 & Infectious Diseases / Harmful Bacteria In Food & Drink, Healthcare & Hospitality
自供电开门系统移除触点
  • 批准号:
    58892
  • 财政年份:
    2020
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Feasibility Studies
Covid-19 PPE - PeRSo Powered Air-Purifying Respirator (PAPR)
Covid-19 PPE - PerSo 动力空气净化呼吸器 (PAPR)
  • 批准号:
    58010
  • 财政年份:
    2020
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Feasibility Studies
AI powered digital service for tracking, supporting and managing obese patients during and after Covid-19
人工智能驱动的数字服务,用于在 Covid-19 期间和之后跟踪、支持和管理肥胖患者
  • 批准号:
    70282
  • 财政年份:
    2020
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Feasibility Studies
Development of a Simple Air- and O2-Powered Ventilator for Care of COVID-19 Patients
开发用于护理 COVID-19 患者的简单空气和 O2 动力呼吸机
  • 批准号:
    555180-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 9.49万
  • 项目类别:
    Alliance Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了